Abstract:<span class="paragraphSection">BackgroundXIAP-associated factor 1 (XAF1) is a pro-apoptotic tumor suppressor whose expression is inactivated in many human malignancies. To explore the XAF1's candidacy for a suppressor in the pathogenesis of human glioma, we investigated its expression and function in tumor cell lines and tissues.MethodsExpression study was performed using quantitative RT-PCR and immunoblot assays. Functional interplay between XAF1 and AMPK was determined by gene transfection, siRNA-mediated depletion.ResultsXIAP-associated factor 1 (XAF1) is a pro-apoptotic tumor suppressor whose expression is inactivated in many human malignancies. In this study, we explored the XAF1's candidacy for a suppressor in human glioma pathogenesis. XAF1 reduction is more common in high grade tumors versus low grade tumors and tightly associated with aberrant hypermethylation at 7 CpG sites in the 5' proximal region of the promoter. XAF1 expression decreases proliferation and colony-forming ability of glioma cells while its depletion enhances cellular resistance to genotoxic drugs, such as temozolomide (TMZ), etoposide and cisplatin. The XAF1 promoter is activated in response to TMZ through JNK-IRF-1 signaling and its activation greatly increases cellular response to TMZ-induced cell death. Furthermore, XAF1 promotes autophagic cell death (ACD) by activating AMP-activated protein kinase (AMPK) in a XIAP-independent manner. Both AMPK-activating and ACD-inducing effects of XAF1 are linked to its activity to decrease intracellular ATP level, oxygen consumption, and mitochondrial membrane potential. XAF1 proteins translocate to the mitochondria and the zinc finger (ZF) 6 domain is essential for its mitochondrial distribution. Consistently, a mutant XAF1 lacking the ZF6 fails to decrease ATP level, activate AMPK, and trigger AMPK-mediated autophagic cell death. Collectively, this study demonstrates that epigenetic inactivation of XAF1 contributes to the malignant progression of human glioma by rendering tumor cells a survival advantage via the attenuation of AMPK signaling.ConclusionsEpigenetic inactivation of XAF1 contributes to the malignant progression of human glioma by rendering tumor cells a survival advantage via the attenuation of AMPK signaling.Legal entity responsible for the studyThe authors.FundingNational Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2018R1D1A1B07041512).DisclosureAll authors have declared no conflicts of interest.</span>

Identification of XAF1 as an endogenous AKT inhibitor

AIP1 is Critical in Transducing IRE1-mediated Endoplasmic Reticulum Stress Response

XIAP-associated factor 1 (XAF1) suppresses angiogenesis in mouse endothelial cells.

I Kappa B Kinase Epsilon And Tank-Binding Kinase 1 Activate Akt By Direct Phosphorylation

Data from FoxO Transcription Factors Promote AKT Ser473 Phosphorylation and Renal Tumor Growth in Response to Pharmacologic Inhibition of the PI3K–AKT Pathway

XAF1 promotes osteoclast apoptosis by antagonizing the XIAP-caspase axis

ABL1-mediated phosphorylation promotes FOXM1-related tumorigenicity by Increasing FOXM1 stability

Supplementary Figures 1 - 5 from FoxO Transcription Factors Promote AKT Ser473 Phosphorylation and Renal Tumor Growth in Response to Pharmacologic Inhibition of the PI3K–AKT Pathway

Macrophage Alpha 1 Amp-Activated Protein Kinase (alpha 1ampk) Antagonizes Fatty Acid-Induced Inflammation Through Sirt1

XIAP-associated factor 1 (XAF1), a novel target of p53, enhances p53-mediated apoptosis via post-translational modification.

Xaf1 can cooperate with TNFα in the induction of apoptosis, independently of interaction with XIAP

XAF1 promotes neuroblastoma tumor suppression and is required for KIF1Bβ-mediated apoptosis

XAF1 enhances temozolomide induced autophagic cell death through AMPK signaling pathway

AKT-phosphorylated FOXO1 Suppresses ERK Activation and Chemoresistance by Disrupting IQGAP1-MAPK Interaction.

XAF1 overexpression inhibits the malignant progression and cisplatin resistance of NSCLC by activating endoplasmic reticulum stress

XAF1 prevents hyperproduction of type I interferon upon viral infection by targeting IRF7

CKIP-1 regulates macrophage proliferation by inhibiting TRAF6-mediated Akt activation

Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates Akt signaling

Interactions Between XIAP Associated Factor 1 and a Nuclear Co-Activator, CBP, in Colon Cancer Cells.

Trihydrophobin 1 Is A New Negative Regulator Of A-Raf Kinase

ARF-dependent regulation of ATM and p53 associated KZNF (Apak) protein activity in response to oncogenic stress.